Literature DB >> 25757119

The effects of balanced blood component resuscitation and crystalloid administration in pediatric trauma patients requiring transfusion in Afghanistan and Iraq 2002 to 2012.

Mary J Edwards1, Michael B Lustik, Margaret E Clark, Kevin M Creamer, David Tuggle.   

Abstract

BACKGROUND: Component balanced resuscitation and avoidance of crystalloids in traumatically injured adults requiring massive transfusion are beneficial. Evidence for children is lacking.
METHODS: After institutional review board approval was obtained, the Department of Defense Trauma Database identified 1,311 injured children 14 years or younger requiring transfusion after an injury and admitted to a deployed US military hospital from 2002 to 2012. Logistic regression determined risk factors for high-volume (≥40 mL/kg) or massive (≥70 mL/kg) transfusions. The effects of crystalloid and balanced component resuscitation in the first 24 hours were assessed.
RESULTS: Nine hundred seven patients had recorded data sufficient for analysis. Two hundred twenty-four children received high-volume transfusion, and 77 received massive transfusions. Mortality was significantly higher for massive transfusions and high-volume transfusions than others (25% vs. 10% and 19% vs. 9%, respectively). Age of less than 4 years, penetrating injury, and Injury Severity Score (ISS) greater than 15 were associated with high-volume transfusions; an ISS greater than 15 and penetrating injury were associated with massive transfusions. Increased crystalloid administration showed a significant positive association with hospital days and intensive care unit days for both massive and high-volume transfusions, as well as a significant positive association with increased ventilator days in patients with high-volume transfusions. Balanced component resuscitation was not associated with improved measured outcomes and was independently associated with a higher mortality when all transfused patients were considered.
CONCLUSION: In this cohort, heavy reliance on crystalloid for resuscitation had an adverse effect on outcomes. Balanced component resuscitation did not improve outcomes and was associated with higher mortality when all transfused patients were considered. Further study is needed regarding efficacy and clinical triggers for the implementation of massive transfusion in children. LEVEL OF EVIDENCE: Prognostic study, level IV.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25757119     DOI: 10.1097/TA.0000000000000469

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  10 in total

1.  Association of Blood Component Ratios With 24-Hour Mortality in Injured Children Receiving Massive Transfusion.

Authors:  Elissa K Butler; Brianna M Mills; Saman Arbabi; Eileen M Bulger; Monica S Vavilala; Jonathan I Groner; Lynn G Stansbury; John R Hess; Frederick P Rivara
Journal:  Crit Care Med       Date:  2019-07       Impact factor: 7.598

2.  Clinical and laboratory predictors of blood loss in young swine: a model for pediatric hemorrhage.

Authors:  Xiaoming Shi; Mary J Edwards; Jordan Guice; Richard Strilka; Brandon Propper
Journal:  Pediatr Surg Int       Date:  2018-05-28       Impact factor: 1.827

3.  The Evolution of Blood Product Use in Trauma Resuscitation: Change Has Come.

Authors:  Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2021-11-02       Impact factor: 3.747

4.  Plasma and Platelet Transfusion Strategies in Critically Ill Children Following Severe Trauma, Traumatic Brain Injury, and/or Intracranial Hemorrhage: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.

Authors:  Robert Russell; David F Bauer; Susan M Goobie; Thorsten Haas; Marianne E Nellis; Daniel K Nishijima; Adam M Vogel; Jacques Lacroix
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.624

5.  Research Priorities for Plasma and Platelet Transfusion Strategies in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.

Authors:  Marianne E Nellis; Kenneth E Remy; Jacques Lacroix; Jill M Cholette; Melania M Bembea; Robert T Russell; Marie E Steiner; Susan M Goobie; Adam M Vogel; Gemma Crighton; Stacey L Valentine; Meghan Delaney; Robert I Parker
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.971

Review 6.  Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Ian K Maconochie; Richard Aickin; Mary Fran Hazinski; Dianne L Atkins; Robert Bingham; Thomaz Bittencourt Couto; Anne-Marie Guerguerian; Vinay M Nadkarni; Kee-Chong Ng; Gabrielle A Nuthall; Gene Y K Ong; Amelia G Reis; Stephen M Schexnayder; Barnaby R Scholefield; Janice A Tijssen; Jerry P Nolan; Peter T Morley; Patrick Van de Voorde; Arno L Zaritsky; Allan R de Caen
Journal:  Resuscitation       Date:  2020-10-21       Impact factor: 5.262

7.  Recommendations on RBC Transfusion in Critically Ill Children With Nonlife-Threatening Bleeding or Hemorrhagic Shock From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Oliver Karam; Robert T Russell; Paul Stricker; Adam M Vogel; Scot T Bateman; Stacey L Valentine; Philip C Spinella
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

8.  Development of transfusion guidelines for injured children using a Modified Delphi Consensus Process.

Authors:  A Francois Trappey; Kyle M Thompson; Nathan Kuppermann; Jacob T Stephenson; Miriam A Nuno; Hilary A Hewes; Sage R Meyers; Rachel M Stanley; Joseph M Galante; Daniel K Nishijima
Journal:  J Trauma Acute Care Surg       Date:  2019-10       Impact factor: 3.313

Review 9.  Hemostatic Balance in Severe Trauma.

Authors:  Thorsten Haas; Melissa M Cushing
Journal:  Front Pediatr       Date:  2020-11-11       Impact factor: 3.418

10.  Executive Summary 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Jerry P Nolan; Ian Maconochie; Jasmeet Soar; Theresa M Olasveengen; Robert Greif; Myra H Wyckoff; Eunice M Singletary; Richard Aickin; Katherine M Berg; Mary E Mancini; Farhan Bhanji; Jonathan Wyllie; David Zideman; Robert W Neumar; Gavin D Perkins; Maaret Castrén; Peter T Morley; William H Montgomery; Vinay M Nadkarni; John E Billi; Raina M Merchant; Allan de Caen; Raffo Escalante-Kanashiro; David Kloeck; Tzong-Luen Wang; Mary Fran Hazinski
Journal:  Resuscitation       Date:  2020-10-21       Impact factor: 6.251

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.